If Drug Discovery is challenging and complex, Drug development is too. Once a lead compound has been selected for development as a potential “Drug Candidate”, a viable manufacturing process must be identified and much earlier. There is little point in having the millennium’s compound if you are not able to produce it under the most favorable conditions!

Routes assessment
Often, the initial synthetic route designed for the synthesis of the “Drug Candidate” is inappropriate for large scale manufacturing. Thus, chemical process research is conducted to identify a synthetic process that is:
• Efficient.
• Reliable.
• Economical.
• Safe.
Our teams use a variety of tools in conducting chemical process development. One of them is the combined use of robotics, statistical and analytical methods, but scientific knowledge too. The kilolab laboratory is used as support for process validation.
Support to chemical development
This support provides our customers with:
•The identification and synthesis of by products, the synthesis of metabolites, the synthesis of cold compounds before transposition to radio labeled compounds (D, ¹³C, ¹⁵N, ¹⁸O)
Support for preclinical and clinical programs
Preclinical studies require some quantities of the “Drug Candidate”. Diverchim is able to provide its customers with the first batch for experiments (until now non cGMP, but attainment of cGMP status is under-way) The Quality Assurance Departments of many pharmaceutical companies have evaluated Diverchim’s procedures as being quasi cGMP. Our integrated approach and expertise in chemical process development add value to our partner’s activities by decreasing development time from discovery to the market.

Confidentiality Intellectual property
We assure the complete confidentiality and technology transfer in the case of exclusivemethodology development and support for patent filling. We offer more than a service.Why not contacts us today?